- $177.44m
- $62.41m
- $6.39m
U.S. RESEARCH ROUNDUP- Airbnb, Post Holdings, Syndax Pharmaceuticals
Korro Bio Inc reports results for the quarter ended September 30 - Earnings Summary
Korro Bio Inc expected to post a loss of $2.61 a share - Earnings Preview
Brief: Korro Announces Regulatory Filing For Initiation Of KRRO-110 First-In-Human Study
Korro Bio Inc expected to post a loss of $2.61 a share - Earnings Preview
Korro Bio Inc reports results for the quarter ended in June - Earnings Summary
Korro Bio Inc expected to post a loss of $2.39 a share - Earnings Preview
Korro Bio Inc reports results for the quarter ended in March - Earnings Summary
Brief: Korro Bio Files For Offering Of Up To 1.2 Mln Common Shares By The Selling Stockholders
Korro Bio Inc expected to post a loss of $2.51 a share - Earnings Preview
Korro Bio Inc reports results for the quarter ended in December - Earnings Summary
U.S. RESEARCH ROUNDUP-Acuity Brands, CSG Systems International, Nuvation Bio
Korro Bio Inc expected to post a loss of $2.36 a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Korro Bio, Arrowhead Pharma, Structure Therapeutics
Korro Bio rises after HCW starts with 'buy' rating
Brief: Frequency Therapeutics Gave Notice To Oppenheimer Of Termination Of Sales Deal Pursuant To Section 11(B) Thereof, Effective Immediately
Frequency Therapeutics Inc reports results for the quarter ended in June - Earnings Summary
Brief: Frequency Therapeutics, Inc. Q2 EPS USD -0.3
Frequency Therapeutics Inc expected to post a loss of 36 cents a share - Earnings Preview